Search results

Jump to navigation Jump to search

Page title matches

  • ...wing oral nutrient ingestion, or postprandially."<ref>{{MeSH}}</ref> Thus, incretin is an insulin [[secretagogue]].
    288 bytes (34 words) - 01:42, 7 October 2013
  • 181 bytes (26 words) - 19:08, 7 September 2009
  • Auto-populated based on [[Special:WhatLinksHere/Incretin]]. Needs checking by a human.
    462 bytes (59 words) - 17:25, 11 January 2010

Page text matches

  • ...wing oral nutrient ingestion, or postprandially."<ref>{{MeSH}}</ref> Thus, incretin is an insulin [[secretagogue]].
    288 bytes (34 words) - 01:42, 7 October 2013
  • {{r|Incretin}}
    261 bytes (33 words) - 14:09, 8 January 2010
  • Auto-populated based on [[Special:WhatLinksHere/Incretin]]. Needs checking by a human.
    462 bytes (59 words) - 17:25, 11 January 2010
  • ...emicals, such as [[glucagon-like peptide 1]]([[GLP-1]]), a member of the [[incretin]] class, also called enteroglucagon. These chemicals variously have effects
    981 bytes (142 words) - 09:38, 23 September 2008
  • ...has been shown to improve postprandial glycaemic control, being a potent [[incretin]] mimetic. A GLP-1 agonist, [[exenatide]], has not yet been approved for us
    18 KB (2,561 words) - 10:26, 24 July 2011
  • ...e journal| author=Amori RE, Lau J, Pittas AG| title=Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. | journal= * [[Incretin]] mimetics. Incretin is an insulin [[secretagogue]].
    98 KB (13,470 words) - 13:28, 10 February 2023
  • ...tes treatments, other than metformin and some of the newer classes such as incretin analogues, it often causes weight gain.
    21 KB (2,988 words) - 06:24, 9 October 2013
  • *Did [[user:Robert Badgett|Robert]] really call us all ''[[incretin|cretins]]''??? No, my mistake!
    19 KB (2,982 words) - 05:02, 8 March 2024